Troeberg Linda, Nagase Hideaki
The Kennedy Institute of Rheumatology Division, Imperial College London, London, UK.
Biochim Biophys Acta. 2012 Jan;1824(1):133-45. doi: 10.1016/j.bbapap.2011.06.020. Epub 2011 Jul 8.
Osteoarthritis is a common joint disease for which there are currently no disease-modifying drugs available. Degradation of the cartilage extracellular matrix is a central feature of the disease and is widely thought to be mediated by proteinases that degrade structural components of the matrix, primarily aggrecan and collagen. Studies on transgenic mice have confirmed the central role of Adamalysin with Thrombospondin Motifs 5 (ADAMTS-5) in aggrecan degradation, and the collagenolytic matrix metalloproteinase MMP-13 in collagen degradation. This review discusses recent advances in current understanding of the mechanisms regulating expression of these key enzymes, as well as reviewing the roles of other proteinases in cartilage destruction. This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.
骨关节炎是一种常见的关节疾病,目前尚无改善病情的药物。软骨细胞外基质的降解是该疾病的核心特征,人们普遍认为这是由蛋白酶介导的,这些蛋白酶降解基质的结构成分,主要是聚集蛋白聚糖和胶原蛋白。对转基因小鼠的研究证实了含血小板反应蛋白基序的解聚素金属蛋白酶5(ADAMTS-5)在聚集蛋白聚糖降解中的核心作用,以及胶原酶基质金属蛋白酶MMP-13在胶原蛋白降解中的作用。本综述讨论了目前对这些关键酶表达调控机制的最新认识进展,并回顾了其他蛋白酶在软骨破坏中的作用。本文是名为:溶酶体发现50年后的蛋白水解的特刊的一部分。